OpenEden vs Enzyme — how do they compare? OpenEden trades at Rp995.77 (market cap Rp400,42M, Rp1,94T 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: OpenEden is far larger — about 3× Enzyme's market cap, and OpenEden's supply is capped (402,6M / 1B EDEN (41%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold OpenEden for 8 Days and Enzyme for 29 Days on average.
| EDEN | MLN | |
|---|---|---|
Market Cap | Rp400,42M | Rp134,13M |
Volume (24h) | Rp1,94T | Rp104,56M |
Circulating Supply | 402,6M / 1B EDEN (41%) | 3,3M MLN |
Typical Hold Time | 8 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
EDEN is trading at Rp1,466.29 with a market cap of Rp547.01M, showing bullish technical signals across moving averages and oscillators. The token is approaching the pivot point resistance at Rp1,160 with strong support at Rp917. With only 41% of the 1M max supply in circulation and an average hold time of 8 days, the token shows moderate distribution and short-term holding patterns. Recent technical indicators show mixed signals with RSI levels indicating overbought conditions while ADX suggests strong trend momentum.
Overall outlook remains cautiously bullish with key opportunities in potential breakout above resistance levels. Major risks include high RSI overbought conditions and limited liquidity due to small market cap. Investors should monitor support levels closely as the token tests key technical boundaries.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
What Pluang investors did over the last 30 days
No sentiment data available yet.
OpenEden is an RWA tokenization platform focused on regulatory compliance and secure on-chain access to real-world assets. Through its regulated entities, it bridges traditional finance and blockchain, enabling transparent and compliant asset participation.
Read more on EDEN →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →